These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. Rider LG; Miller FW JAMA; 2011 Jan; 305(2):183-90. PubMed ID: 21224460 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
7. Using Registry Data to Understand Disease Evolution in Inflammatory Myositis and Other Rheumatic Diseases. Lim LSH; Feldman BM Curr Rheumatol Rep; 2019 Dec; 22(1):2. PubMed ID: 31832893 [TBL] [Abstract][Full Text] [Related]
8. Clinical assessment in juvenile idiopathic inflammatory myopathies and the development of disease activity and damage tools. Pilkington C Curr Opin Rheumatol; 2004 Nov; 16(6):673-7. PubMed ID: 15577603 [TBL] [Abstract][Full Text] [Related]
9. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG; Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic inflammatory muscle disease: clinical aspects. Rider LG; Miller FW Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):37-54. PubMed ID: 10882213 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathies. van der Kooi AJ; de Visser M Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315 [TBL] [Abstract][Full Text] [Related]
13. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Martin N; Krol P; Smith S; Murray K; Pilkington CA; Davidson JE; Wedderburn LR; Rheumatology (Oxford); 2011 Jan; 50(1):137-45. PubMed ID: 20823094 [TBL] [Abstract][Full Text] [Related]
14. Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies. Lundberg IE; Alexanderson H Nat Clin Pract Rheumatol; 2007 May; 3(5):282-90. PubMed ID: 17471247 [TBL] [Abstract][Full Text] [Related]
15. Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis. Nuño L; Joven B; Carreira P; Maldonado V; Larena C; Llorente I; Tomero E; Barbadillo MC; García-de la Peña P; Ruiz L; López-Robledillo JC; Moruno H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; Monteagudo I; García-De Yébenes MJ; López-Longo FJ Reumatol Clin; 2017; 13(6):331-337. PubMed ID: 27616211 [TBL] [Abstract][Full Text] [Related]
16. International collaboration including patients is essential to develop new therapies for patients with myositis. Lundberg IE; Vencovsky J Curr Opin Rheumatol; 2017 May; 29(3):234-240. PubMed ID: 28207492 [TBL] [Abstract][Full Text] [Related]
17. Classification and prognosis of inflammatory muscle disease. Miller FW Rheum Dis Clin North Am; 1994 Nov; 20(4):811-26. PubMed ID: 7855323 [TBL] [Abstract][Full Text] [Related]
18. Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population. Caughey GE; Gabb GM; Ronson S; Ward M; Beukelman T; Hill CL; Limaye V JAMA Intern Med; 2018 Sep; 178(9):1224-1229. PubMed ID: 30073275 [TBL] [Abstract][Full Text] [Related]
20. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Miller FW Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i82-5. PubMed ID: 22460145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]